EUVIMEDEUVIMED entdecken
Fallbericht

Pediatric growth hormone and prolactin-secreting tumor associated with an AIP mutation and a MEN1 variant of uncertain significance

Maria Inês Alexandre iD, Claudia C Faria, Ana Gomes, Maria João Bugalho

Journal of Pediatric Endocrinology and Metabolism · 2023

DOI: 10.1515/jpem-2022-0488 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Pediatric Endocrinology and Metabolism, 2023. Verfasst von Maria Inês Alexandre und 3 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Department, Hospital de Santa Maria, Centro Hospitalar Universitário de Lisboa Norte, Lisbon, Portugal. Hauptthemen laut MEDLINE: Gigantism, Human Growth Hormone, Multiple Endocrine Neoplasia Type 1, Pituitary Neoplasms. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Pituitary gigantism is a rare condition and it often has an identifiable genetic cause. In this article we report a case of a young girl with pituitary gigantism and two genetic changes. Case presentation A 15-year-old girl with primary amenorrhea was diagnosed with a growth hormone (GH) and prolactin (PRL)-producing tumor, needing surgery and medical treatment with octreotide in order to achieve disease control. The co-occurrence of an AIP mutation and a MEN1 variant of uncertain significance was demonstrated in this patient. The germline mutation involving AIP was inherited from her father who at the age of 55 was unaffected and the MEN1 variant was a de novo duplication of the region 11q13.1. The latter variant, not previously reported, is unlikely to be pathogenic. Nonetheless, screening for other components of multiple endocrine neoplasia type 1 (MEN1) was performed and proved negative.

Conclusions

The rare co-occurrence of an AIP mutation and a MEN 1 variant of uncertain significance was demonstrated in this patient.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GigantismHuman Growth HormoneMultiple Endocrine Neoplasia Type 1Pituitary NeoplasmsAdolescentFemaleHumansGerm-Line MutationGrowth HormoneIntracellular Signaling Peptides and ProteinsMutationProlactin

Stichwörter der Autor:innen

genetic testinggigantismgrowth hormone

Substanzen

Growth HormoneHuman Growth HormoneIntracellular Signaling Peptides and ProteinsProlactin

Autor:innen und Institutionen

  • Endocrinology Department, Hospital de Santa Maria, Centro Hospitalar Universitário de Lisboa Norte, Lisbon, Portugal.
  • Neurosurgery Department, Hospital de Santa Maria, Centro Hospitalar Universitário de Lisboa Norte, Lisbon, Portugal.
  • Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal.

ORCID-Profile: Maria Inês Alexandre

Zitieren

APA

Alexandre, M. I., Faria, C. C., Gomes, A., & Bugalho, M. J. (2023). Pediatric growth hormone and prolactin-secreting tumor associated with an AIP mutation and a MEN1 variant of uncertain significance. Journal of Pediatric Endocrinology and Metabolism. https://doi.org/10.1515/jpem-2022-0488

Vancouver

Alexandre MI, Faria CC, Gomes A, Bugalho MJ. Pediatric growth hormone and prolactin-secreting tumor associated with an AIP mutation and a MEN1 variant of uncertain significance. Journal of Pediatric Endocrinology and Metabolism. 2023. doi:10.1515/jpem-2022-0488

BibTeX
@article{Alexandre2023,
  author = {Alexandre, Maria Inês and Faria, Claudia C and Gomes, Ana and Bugalho, Maria João},
  title = {Pediatric growth hormone and prolactin-secreting tumor associated with an AIP mutation and a MEN1 variant of uncertain significance},
  journal = {Journal of Pediatric Endocrinology and Metabolism},
  year = {2023},
  doi = {10.1515/jpem-2022-0488}
}
Kostenlos starten →